-
While it is not in the top tier of contraceptive effectiveness, the diaphragm remains an option as a female-controlled method of birth control. What do you know about this form of family planning?
-
Many women might choose the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera) for its ease of use, but they might discontinue the method due to irregular bleeding.
-
Findings from a new national report reflect an increase in the use of early medication abortion.
-
While the human papillomavirus (HPV) vaccine has been approved for use in men, how many are open to receiving it? New research indicates men might be more willing to receive vaccination when they learn the vaccine can prevent cancer.
-
Although the relationship between intrauterine infection and preterm labor (PTL) has been addressed in previous OB/GYN Clinical Alerts, I cannot pass up the opportunity to review a recent paper that sheds new light on a rational approach to PTL.
-
Recent investigation into the molecular pathogenesis of epithelial ovarian cancer has implicated two dominant phenotypes.
-
Obesity is a growing problem in the united states. the pun would be funny were it not for the adverse influence that the obesity epidemic has had on health care outcomes.
-
In this issue: Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
Ova-301 was a large (n = 672), open-label phase III trial comparing pegylated liposomal doxorubicin (PLD) to combination PLD and trabectedin (PT) in women with recurrent ovarian cancer. The trial's overall population was previously reported and demonstrated a significant impact on PFS, without a significant improvement in OS.
-
Despite the important progress that has been made in obstetrics, in general, over the last 20 years, shoulder dystocia remains an enigma. Given the rising rate of maternal obesity and gestational diabetes, it is unlikely that the rate of this dangerous complication will be lowered in the near future.